Journal
BRITISH JOURNAL OF GENERAL PRACTICE
Volume 70, Issue 697, Pages E525-E533Publisher
ROYAL COLL GENERAL PRACTITIONERS
DOI: 10.3399/bjgp20X710873
Keywords
cardiovascular diseases; lipids; primary health care; retrospective studies; statins
Categories
Funding
- National Institute for Health Research (NIHR) Biomedical Research Centre, Oxford
- Health Foundation [7599]
- NHS England
Ask authors/readers for more resources
Background Since 2014 English national guidance recommends 'high-intensity' statins, reducing low-density lipoprotein [LDL] cholesterol by >= 40%. Aim To describe trends and variation in low-/medium-intensity statin prescribing and assess the feasibility of rapid prescribing behaviour change. Design and setting A retrospective cohort study using OpenPrescribing data from all 8142 standard NHS general practices in England from August 2010 to March 2019. Method Statins were categorised as high- or low-/medium-intensity using two different thresholds, and the proportion prescribed below these thresholds was calculated. The authors plotted trends and geographical variation, carried out mixed-effects logistic regression to identify practice characteristics associated with breaching of guidance, and used indicator saturation to identify sudden prescribing changes. Results The proportion of statins prescribed below the recommended 40% LDL-lowenng threshold has decreased gradually from 80% in 2011/2012 to 45% in 2019: the proportion below a pragmatic 37% threshold decreased from 30% to 18% in 2019. Guidance from 2014 had minimal impact on trends. Wide variation was found between practices (interdecile ranges 20% to 85% and 10% to 30% respectively in 2018). Regression identified no strong associations with breaching of guidance. Indicator saturation identified several practices exhibiting sudden changes towards greater guideline compliance. Conclusion Breaches of guidance on choice of statin remain common, with substantial variation between practices. Some have implemented rapid change, indicating the feasibility of rapid prescribing behaviour change. This article discusses the potential for a national strategic approach, using data and evidence to optimise care, including targeted education alongside audit and feedback to outliers through services such as OpenPrescribing.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available